Arrant's platform reduces development time and costs associated with companion diagnostic development
From development to commercialization, Arrant provides a data-driven approach to CDx partnerships leveraging a broad-panel platform used by thousands of oncologists.
Arrant Leverages its research infrastructure to expedite Cdx development
Our bioinformatics expertise and software tools enable us to analyze and interpret complex biological data.
Arrant establishes joint research teams combining disciplines from its bio-repository, computational biology, medical, bioinformatics, and machine learning to work alongside your teams with a goal of accelerating CDx development.